Zobrazeno 1 - 4
of 4
pro vyhledávání: '"María José Díaz-Huízar"'
Autor:
Sergio Rodríguez-Rodríguez, Lorena Guerrero-Torres, María José Díaz-Huízar, Alan Pomerantz, María del Pilar Ortíz-Vilchis, Roberta Demichelis-Gómez
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 4, Pp 476-481 (2021)
Introduction: We performed cost-effectiveness and cost-utility analyses of the modified International Consortium on Acute Promyelocytic Leukemia protocol in Mexico for the treatment of acute promyelocytic leukemia Acute Promyelocytic Leukemia. Method
Externí odkaz:
https://doaj.org/article/4c72fd642ea840eb991a6c563a8b24e9
Autor:
María del Pilar Ortíz-Vilchis, Roberta Demichelis-Gómez, María José Díaz-Huízar, Lorena Guerrero-Torres, Sergio Rodríguez-Rodríguez, Alan Pomerantz
Publikováno v:
Hematology, Transfusion and Cell Therapy, Volume: 43, Issue: 4, Pages: 476-481, Published: 29 NOV 2021
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 4, Pp 476-481 (2021)
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 4, Pp 476-481 (2021)
Introduction We performed cost-effectiveness and cost-utility analyses of the modified International Consortium on Acute Promyelocytic Leukemia protocol in Mexico for the treatment of acute promyelocytic leukemia Acute Promyelocytic Leukemia. Methods
Autor:
Diego-Abelardo Álvarez-Hernández, María-José Díaz-Huízar, Chávez, Alberto González, García-Rodríguez-Arana, Rodolfo, Jorge-Alberto Ascencio-Aragón, Hernández-Ponce, Yolanda, Alvarez-Sánchez, Mariana, Martínez-Juárez, Luis, Estefan-Melgarejo, Emmanuel, Vazquez, Rosalino, Ana-María Fernández-Presas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d64e3444d6f4160ee23470311efd016
Autor:
Sergio Rodríguez-Rodríguez, Xavier López-Karpovitch, Roberta Demichelis-Gómez, Alan Pomerantz, Monica Goldberg-Murow, Olga Barrales-Benitez, María José Díaz-Huízar, Alvaro Aguayo, Georgina Barrera-Lumbreras
Publikováno v:
Archives of medical research. 48(2)
The correct classification of acute leukemias (AL) is an essential part in the evaluation of any patient with this disease. Historically, CD117 has been an important asset in the diagnosis of patients with mixed-phenotype acute leukemia (MPAL). In an